Patent · US Expired

2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents

US6790841B2 · kind B2 · utility

4Cited by
2References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 14, 2002
Grant dateSep 14, 2004
Priority date
Expiry dateJan 14, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65616
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds which are active against viruses have the following Formulas: wherein B is a purine or pyrimidine heterocyclic ring and is preferably selected from the group consisting of 6-aminopurine (adenine), 2,6-diaminopurine, 2-amino-6-azidopurine, 2-amino-6-cyclopropylaminopurine, 6-hydroxypurine (hypoxanthine), 2-amino-6-halo substituted purines, 2-amino-6-alkoxy substituted purines, 2-amino-6-hydroxypurine (guanine), 3-deazapurines, 7-deaza-purines, 8-azapurines, cytosine, 5-halo substituted cytosines, 5-alkyl substituted cytosines, thymine, uracil and 6-azapyrimidines; X is O; and, R1 and R2 are alkyl or aryl groups. The compounds of the present invention also include the R- and S-enantiomers of the above compounds. The R1X and/or R2X can also be amino acid residues with X as NH.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.